Biochemical and genetic studies of cells from a wide variety of species have demonstrated that the signals leading to differentiation are highly conserved and that in many cases, the same compounds are involved in both cell growth and transformation. Two general hypotheses have been suggested to explain why common signaling pathways can lead to different endpoints. First, it has been suggested that both the amplitude and the duration of a particular signal can influence the final biological endpoint (reviewed in reference 18). Alternatively, differences in phenotypes have been attributed to differences in specific cellular environments (both internal and external). While it is likely that both factors contribute to the final biological endpoint, it is important to investigate a number of differentiation systems in order to identify their relative contributions.
One major problem, particularly with respect to neuronal cell differentiation, has been the limited availability of appropriate model systems. The best-characterized system to date is the pheochromocytoma cell line PC12, which is derived from a transplantable rat adrenal pheochromocytoma (13) . One problem that potentially complicates this system is that the genes leading to immortalization and transformation of PC12 cells have not been identified. However, a major advantage of PC12 cells is that different factors yield different biological endpoints. Epidermal growth factor (EGF) treatment of PC12 cells induces mitogenesis, nerve growth factor whereas or fibroblast growth factor (FGF) treatment induces differentiation to a phenotype with characteristics of sympathetic neurons. The induction of differentiation by nerve growth factor has been correlated with prolonged activation of mitogen-activated protein kinases (MAPKs; ERK1 and -2), and microinjection of constitutively activated MEK (MAPKK) (6) or MAPK (10) has been reported to induce PC12 cell differentiation (6) . In addition, it has been shown that Ras and Raf-1 are also able to differentiate PC12 cells (2, 22) . Interestingly, v-raf-mediated differentiation of PC12 cells was reported to occur under conditions in which MAPK activation was not detected (35, 36) . These results led to the model that prolonged MAPK activation is the key mediator of neuronal cell differentiation (reviewed in reference 18) but also raise the possibility of other signaling pathways.
We have generated a cell line (H19-7) derived from early E17 rat hippocampal cells, which provide a neuronal differentiation model for central nervous system neurons (9) . These cells have been conditionally immortalized by expression of a temperature-sensitive simian virus 40 large T antigen. Thus, the H19-7 cells offer the advantage of temporary immortalization which can be effectively reversed to yield cells in a more normal state. Like PC12 cells, H19-7 cells respond differentially to EGF and FGF. At the permissive temperature (33ЊC), EGF treatment induces proliferation; at the nonpermissive temperature (39ЊC), addition of FGF or phorbol 12,13-dibutyrate (PDBu) but not EGF induces differentiation. The differentiated temperature-sensitive T-antigen-immortalized hippocampal cells do not respond mitogenically to serum, but they express neuronal markers such as neurofilaments and brain type II sodium channels and display action potentials (references 8 and 9 and data not shown). Thus, H19-7 cells provide a good model system for testing the role of a variety of signaling molecules in neuronal differentiation.
Analysis of the FGF signaling pathway leading to H19-7 differentiation showed induction of Raf-1 and MEK and a prolonged activation of MAPK. To analyze this pathway further, we transfected these cells with v-raf or an oncogenic human Raf-1-estrogen receptor fusion gene (⌬Raf-1:ER). Use of the ⌬Raf-1:ER construct enabled us to monitor the immediate events following Raf-1 kinase activation. The results indicate that activated Raf-1 can stimulate neuronal differentiation. However, in this cell system, prolonged MAP kinase activity is not sufficient to induce differentiation.
MATERIALS AND METHODS
Materials. Protein A-Sepharose was purchased from Pharmacia. Fetal bovine serum (FBS), Dulbecco modified Eagle medium (DMEM), Bluo-gal, and Geneticin were purchased from Life Technologies Inc. Hygromycin and estradiol were purchased from Sigma (St. Louis, Mo.). EGF (receptor grade) was purchased from Biomedical Technologies (Stoughton, Mass.). Human basic FGF (bFGF; receptor grade) was purchased from Bachem California (Torrance, Calif.). Myelin basic protein (MBP) was from Sigma. Antiphosphotyrosine antibody was purchased from Upstate Biotechnology, Inc. (Lake Placid, N.Y.). Anti-c-Raf-1 antibody was from Santa Cruz Biotechnology Inc. Monoclonal antibody against the hemagglutinin (HA) epitope was purchased from BabCo (Emeryville, Calif.). Anti-MAPK antiserum (antibody 283) was developed as described previously (4) . Antibodies against the high-and middle-molecularweight neurofilament proteins either were purchased from Sigma (high molecular weight) or were a gift from V. Lee (middle molecular weight). Phosphorylated MAPK-specific antibody was purchased from New England Biolabs, Inc. (Beverly, Mass.). Rat immunoglobulin G (IgG) was purchased from Sigma. Plasmid encoding the kinase-inactive MEK was a gift from G. Johnson. A plasmid, EE-MEK-1 2E-CMV, encoding the mutant MEK-2E protein, and a nonexpressing plasmid, EE-CMV, were generated as previously described (38) . Plasmid pLNC⌬MEK1:ER codes for a fusion protein between the estradiol binding domain of the estrogen receptor (29) and the ⌬N3-S218E-S222D form of MEK (17, 18a) . The pCMV-␤-gal expression vector was a gift from V. Sukhatme, the v-raf vector was a gift from U. Rapp, and the pTK-hgr selection vector was a gift from N. Hay. Plasmid DNAs were prepared by CsCl-ethidium bromide gradient centrifugation as described previously (15) or by purification through columns as instructed by the manufacturer (Qiagen, Chatsworth, Calif.). One percent Triton-based lysis buffer (TLB) contains 20 mM Tris (pH 7.9), 137 mM NaCl, 5 mM Na 2 EDTA, 10% glycerol, 1% Triton X-100, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 1 g of aprotinin per ml, 20 M leupeptin, 1 mM sodium orthovanadate (pH 10.0), 1 mM EGTA (pH 8.0), 10 mM NaF, 1 mM tetrasodium PP i , 1 mM ␤-glycerophosphate (pH 7.4), and 0.1 g of p-nitrophenyl phosphate per ml.
Cells. The H19-7 cells were generated from embryonic rat hippocampal cells (9) . The cells were conditionally immortalized by stable transfection with a temperature-sensitive simian virus 40 large T antigen. H19-7 cells were grown in DMEM-10% FBS and maintained at 33ЊC under G418 selection throughout the experiments (9, 33) . To induce differentiation, cells were placed in N2 medium and shifted to 39ЊC prior to treatment with differentiating agents as previously described (8) .
The v-raf-expressing (v-raf) and ⌬Raf-1:ER cells were generated by stably transfecting H19-7 cells with the vectors expressing the mutant oncogenic v-raf or the estradiol-regulated human Raf-1 (⌬Raf-1:ER) (29) by the calcium phosphate precipitation method as described previously (27) . Cells were cotransfected with a pTK-hgr vector expressing a hygromycin resistance gene, and stable transfectants were selected for survival in the presence of 200 g each of hygromycin and Geneticin per ml.
Raf immune complex kinase assay. Raf-1 kinase activity was analyzed by immune complex kinase assay (26) . Cells were washed twice with ice-cold phosphate-buffered saline (PBS) and lysed in 10 mM Tris HCl (pH 7.4)-1% Triton X-100-1 mM EDTA-150 mM NaCl-50 mM NaF-0.1% bovine serum albumin (BSA)-20 g of aprotinin per ml-200 M Na 3 VO 4 -0.2 mM phenylmethylsulfonyl fluoride. The cell debris and nuclei were removed by centrifugation, and the supernatants were incubated with anti-c-Raf antibody (Santa Cruz) for 1.5 h at 4ЊC. Protein A-Sepharose was added for another 30 min. Then the mixtures were loaded onto equal volume of lysis buffer plus 10% sucrose and centrifuged for 20 min at 2,500 rpm. The pellet was washed twice with lysis buffer, twice with PAN [10 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid (PIPES; pH 7.0), 100 mM NaCl, 20 g of aprotinin per ml] plus 0.5% Nonidet P-40, and finally twice with PAN. The pellet was resuspended in 20 l of kinase buffer (20 mM PIPES [pH 7.0], 10 mM MnCl 2 , 20 g of aprotinin per ml, 200 M Na 3 VO 4 ) containing 25 to 50 ng of kinase-inactive MEK-1 prepared as described below. The immunocomplex kinase reaction was initiated by adding 10 Ci of [␥- 32 P]ATP to the mixture and incubated at 30ЊC for 15 to 20 min. The reaction was terminated by adding 2ϫ sodium dodecyl sulfate (SDS)-gel sample buffer and boiled for 2 to 5 min. The samples were resolved on an FIG. 1. Time course of ERK phosphorylation following stimulation of H19-7 cells with EGF or bFGF. H19-7 cells were grown in DMEM-10% FBS, then placed in N2 medium, and shifted to 39ЊC; 48 h later, cells were treated with 10 nM EGF (A) or 10 ng of bFGF per ml (B) for different time intervals. Cell lysates were prepared as described in Materials and Methods, and 25 g of protein was loaded in each lane and resolved by SDS-PAGE in a 7.5% polyacrylamide gel. The proteins were Western blotted and probed with anti-ERK antibody 283. The hybridized bands were detected by ECL and exposed to X-ray film for autoradiography. ERK1 (44 kDa) and ERK2 (42 kDa) bands are indicated with arrows. These results are representative of three independent experiments. VOL. 16, 1996 DIFFERENTIATION OF NEURONAL CELLS BY Raf 1459 SDS-10% gel, and the level of MEK phosphorylation was measured by scanning the dried gels directly with an AMBIS (San Diego, Calif.) image scanner.
To assay ⌬Raf-1:ER kinase activity, 200 g of cellular lysate was incubated with 1.4 g of rat anti-estrogen receptor antibody H222 (kindly provided by Geoffrey Greene) for 90 min at 4ЊC. Thirty microliters of a 1:1 slurry of protein A-Sepharose precoupled with rabbit anti-rat IgG (Sigma) was added to each tube containing the cellular lysate to precipitate the immunocomplexes. ⌬Raf-1:ER kinase activity in immunocomplexes was assayed as in the same manner as described above for Raf-1 kinase activity.
Purification of inactive MEK-1 fusion protein. The His 6 -MEK-1 fusion protein was purified essentially as described by Robbins et al. (25) , with modifications. Briefly, BL21-DE3 cells (Novagen, Madison, Wis.) transformed with pREST-MEK1 (kindly provided by Gary Johnson) were grown in 2ϫYT (16 g of tryptone, per liter, 10 g of yeast extract, and 5 g of NaCl per liter) at 30ЊC until the optical density at 540 nm reached 0.4 to 0.5. Isopropyl-␤-D-thiogalactoside (IPTG) was added to a final concentration of 0.5 mM to induce the expression of histidine-tagged MEK-1 fusion protein for 4 to 5 h. Cells were harvested and lysed in a sonication buffer containing 50 mM NaPO 4 (pH 7.8) and 0.3 M NaCl. The lysate was incubated with nickel beads (Ni-nitrilotriacetic acid; Qiagen) and washed with the sonication buffer containing 25 mM imidazole, and then the fusion protein was eluted with stepwise increases of imidazole concentrations from 50 to 750 mM. The eluted fusion proteins were further purified by using Centricon-30 columns. The purified inactive MEK-1 protein was stored at 100 ng/l in a storage buffer containing 20 mM Tris (pH 7.5), 1 mM dithiothreitol, (DTT), 1 mM EGTA, 10 mM benzamidine, and 10% glycerol.
Analysis of endogenous MAPK activity. (i) In-gel renaturation assay. MAPK activity was analyzed by an in-gel renaturation assay (5) . Cell extracts (5 to 10 g of total protein) were resolved in an SDS-10% polyacrylamide gel containing 0.1 mg of MBP per ml. After electrophoresis, the gel was washed twice with 50 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES; pH 7.4)-5 mM ␤-mercaptoethanol (buffer A) plus 20% 2-propanol to remove SDS. The gel was then reequilibrated with buffer A at room temperature for an hour, which was followed by two changes of 6 M guanidine HCl in buffer A to denature the proteins. Subsequently, the enzymes on the gel were renatured with two changes of 500 ml of buffer A containing 0.04% Tween 20 at 4ЊC for 16 h. The renatured gel was then incubated with buffer B containing 25 mM HEPES (pH 7.4), 10 mM MgCl 2 , 100 M sodium vanadate, and 5 mM ␤-mercaptoethanol at 30ЊC for 30 min. The phosphorylation assay was conducted by layering 10 ml of buffer B plus 50 M [␥-32 P]ATP (250 Ci) onto the renatured gel and incubating the gel at 30ЊC for 1 h. The reaction was terminated by immersing the gel in 5% trichloroacetic acid and 10 mM sodium pyrophosphate, and the gel was washed extensively with this solution to remove unreacted radioactivity. Autoradiograms were developed by exposing the X-ray film to the dried gels with an intensifying screen. Quantitation of the MBP phosphorylation by the MAPKs was measured by directly scanning of the dried gels with an AMBIS image analyzer.
(ii) ERK immunoprecipitation assay. One hundred micrograms of cellular lysate was incubated with 2 l of ERK-specific antibodies and assayed as previ- Assay of neurofilament expression. High-and middle-molecular-weight neurofilament proteins were detected by immunocytochemistry as previously described (8) .
Assay of endogenous MEK activity. Cells were treated with estradiol for different lengths of time at either 33 or 39ЊC, and cell extracts were prepared with 1% TLB as described in the assay for MAPK. Briefly, 30 g of protein was incubated with 2 g of inactive ERK1 protein in a reaction mixture containing 40 mM HEPES (pH 7.8), 10 mM MgCl 2 , 1 mM DTT, 40 M ATP, and 10 Ci of [␥-
32 P]ATP for 30 min at 30ЊC. The reaction mixture was separated by SDSpolyacrylamide gel electrophoresis (PAGE) in a 10% polyacrylamide gel. The proteins were transferred to nitrocellulose membranes and exposed to X-ray film for autoradiography. Membranes were subsequently probed with an antiphosphotyrosine antibody and detected by enhanced chemiluminescence (ECL).
Assay of MEK-2E activity. ⌬Raf-1:ER cells were plated at 3 ϫ 10 5 /100-mmdiameter dish 1 day before transfection. Plasmid EE-MEK-2E-CMV (38) and HA-tagged ERK2 (HA-ERK2) (3), 15 and 5 g, respectively, were transfected into ⌬Raf-1:ER cells by the calcium phosphate precipitation method. The empty vector, EE-CMV, was used as a control plasmid. Eighteen hours after transfection and glycerol shock, cells were switched to N2 medium and shifted to 39ЊC; 24 h after the temperature shift, cells were treated with either EGF (10 nM) or bFGF (10 ng/ml) for 5 min or with estradiol (1 M) for 30 min and lysed in 500 l of 1% TLB. The HA-ERK2 proteins in the lysates were immunoprecipitated with a monoclonal antibody, 12CA5, against the HA epitope tag and used for assaying phosphorylation of MBP in vitro (see below).
HA-ERK2 kinase assay. ERK2 kinase activity was assessed by immunoprecipitation of the epitope tag followed by an in vitro phosphorylation assay (20) . Transfected cells were stimulated and lysed with 0.5 ml of ice-cold 1% TLB. Insoluble materials were removed by centrifugation at 14,000 rpm for 10 min at 4ЊC. The cell lysates were then incubated with 25 l of protein A-Sepharose precoupled with antibody 12CA5 specific to the HA epitope (BabCo) for 3 to 16 h at 4ЊC. The immune complexes were washed twice with lysis buffer and once with kinase reaction buffer containing 20 mM HEPES (pH 7.4), 10 mM MgCl 2 , 1 mM DTT, 200 M sodium orthovanadate, and 10 mM p-nitrophenyl phosphate. The MBP phosphorylation reaction mixture was separated by SDS-PAGE on a 12% polyacrylamide gel and then transferred by a Hoefer Semi-Phor transfer apparatus to a nitrocellulose membrane, using a buffer containing 25 mM Tris, 192 mM glycine, and 10% methanol. To quantitate the phosphorylation of MBP, the membrane was directly scanned by an AMBIS image system. The nitrocellulose was blocked with a solution of 5% BSA in 50 mM Tris (pH 7.5)-150 mM NaCl-0.2% Tween 20. Blots were probed with a 1:500 dilution of antibody 12CA5 for detecting the expression of HA-tagged protein. Western blots (immunoblots) were visualized by using ECL reagents (Amersham, Arlington Heights, Ill.). Transient transfection of H19-7 and ⌬Raf-1:ER cells. About 10 5 cells (H19-7 for ⌬Raf-1:ER expression and ⌬Raf-1:ER cells for MEK-2E or ⌬MEK1:ER expression) were seeded in each well in a six-well plate. The next day, cells in each well were cotransfected with 2.5 g of EE-MEK2E-CMV or pLNC⌬MEK1:ER and 2.5 g of pCMV-␤-gal expression vector by the calcium phosphate precipitation method (27) . At 12 to 18 h after transfection, cells were switched to N2 medium and shifted to 39ЊC. At the same time, estradiol, bFGF, or vehicle was added to the N2 medium to differentiate the cells. About 24 to 36 h after the temperature shift and the treatment, cells were fixed and stained for ␤-galactosidase activity (16 Indirect immunofluorescence labeling. At 24 to 48 h after microinjection, the cells were fixed with 3.7% formaldehyde in PBS for 10 min at room temperature and then treated with permeabilizing solution (0.2% [wt/vol] Triton X-100 in 2% formaldehyde-PBS) for 5 min. Fixed cells were blocked with 15% goat serum in PBS for 15 min. Incubations with antibodies against estrogen receptor (10 g/ml) and ␤-galactosidase (1:400 dilution; 5 Prime 3 3 Prime, Inc.) were carried out at 4ЊC overnight or at room temperature for 1 h. Fluorescein isothiocyanate-and Texas red-conjugated goat anti-rabbit IgG or anti-rat IgG (Cappel, Durham, N.C.) was added, and the mixture was incubated for 1 h at room temperature. Between each of the foregoing steps, the sample was extensively washed with PBS. Coverslips with stained cells were mounted with Vectashield mounting medium (Vector Laboratories, Burlingame, Calif.) and examined with a Leitz DMIRB microscope. Images were captured with a charge-coupled device video camera using the public domain NIH image program (National Institutes of Health) and printed with a Sony color printer.
RESULTS
FGF induces prolonged ERK activation in rat hippocampal H19-7 neuronal cells. Rat hippocampal neuronal H19-7 cells were shifted to 39ЊC to inactivate the simian virus 40 T antigen, transferred to serum-free N2 medium for 2 days, and then treated either with 10 ng of FGF per ml, which will differentiate the cells within 2 days, or 10 nM EGF, which will not differentiate the cells (9, 33) . To determine the potential involvement of MAPKs (ERK1 and -2) in FGF-induced differentiation, cell extracts were obtained from 0 to 5 h following treatment and analyzed for ERK activation by a gel shift assay that measures the state of enzyme phosphorylation (Fig. 1) . These results show that ERKs are rapidly activated by both FGF or EGF treatment, but that the activation is prolonged (albeit at a lower level) for up to 5 h in the FGF-treated sample only. These results are consistent with previous results obtained with PC12 cells that have indicated a role for prolonged ERK activation in promoting differentiation of neuronal cells.
Activated Raf-1 induces neuronal differentiation of H19-7 cells. A major pathway by which ERK is activated by tyrosine kinase growth factor receptors involves sequential activation of Ras, Raf-1, and MEK (reviewed in reference 18). To determine whether activated Raf-1 is sufficient to induce neuronal differentiation of H19-7 cells, cells were stably transfected with v-raf at 33ЊC. Immunoblot analysis of the clones with antiRaf-1 antibody showed expression of v-raf both at 33ЊC in serum and at 33 and 39ЊC in N2 medium (Fig. 2) . Two forms of the v-raf product, one containing and one lacking the Gag fusion protein, are expressed as previously described (24) . Many of the clones display neurite extension even at 33ЊC, but shifting the cells to 39ЊC to inactivate T antigen resulted in more extensive neurite formation (Fig. 3A to C) . These results indicate that activated Raf-1 can induce neuronal differentiation of H19-7 cells.
To analyze the initial signals generated by Raf-1, H19-7 cells were transfected with a vector expressing ⌬Raf-1:ER (29) . Upon exposure to estradiol, ⌬Raf-1:ER is activated within minutes, enabling one to monitor early signaling events (29) (see Fig. 5 ). Analysis of stably transfected cells with an antibody to the estrogen receptor showed expression of ⌬Raf-1:ER protein at both 33 and 39ЊC ( Fig. 2A, right) . After addition of 1 M estradiol to the ⌬Raf-1:ER cells, the amount of ⌬Raf-1:ER protein increased with time. As has been reported previously (29) , rapid changes in the phosphorylation state of the endogenous Raf-1 protein yielding a multiplicity of bands can be detected in immunoblots with anti-Raf-1 antibody (which does not detect the ⌬Raf-1:ER fusion protein) following activation of ⌬Raf-1:ER, particularly at 33ЊC (Fig. 2B) . Activation of ⌬Raf-1:ER with 1 M estradiol for 12 to 24 h caused the cells to differentiate at 39ЊC, as judged by morphology and neurite extension ( Fig. 3F and H) , whereas no significant differentiation occurred in the absence of estradiol under these conditions (Fig. 3E) . Concentrations of estradiol as low as 10 nM also promoted cell differentiation (Fig. 4) , but the rate of process formation (36 to 48 h) was slower, comparable to that observed when FGF was used to differentiate the cells. Like the v-raf-expressing cells, the ⌬Raf-1:ER-expressing cells at 33ЊC (the temperature at which T antigen is active) are also capable of morphological differentiation, but only after prolonged activation of ⌬Raf-1:ER by estradiol for at least 3 days ( Fig. 3G ; data not shown). Estradiol treatment of mock-transfected H19-7 cells had no effect on cell differentiation (Fig.  3D) . Differentiation of the ⌬Raf-1:ER cells by estradiol was confirmed by immunostaining for neurofilament expression (Fig. 4) . When cells were switched to 39ЊC for 12 h and then 10 nM estradiol was added for an additional 36 h, significant induction of both high-and middle-molecular-weight neurofilament expression was observed.
To determine whether the differentiation by FGF or ⌬Raf-1:ER was due to activation of Raf-1, the activity of immunoprecipitated Raf was measured by using MEK as a substrate. Fig. 2 . Thirty micrograms of cell extract was assayed for MEK activity, using inactivated ERK1 as a substrate as described in Materials and Methods. The reaction mixture was resolved by SDS-PAGE, blotted onto a nitrocellulose membrane, and exposed to X-ray film for autoradiography. The VOL. 16, 1996 DIFFERENTIATION OF NEURONAL CELLS BY Raf 1463
As shown in Fig. 5A , at 39ЊC, endogenous Raf-1 activity was detectable in H19-7 cells treated with FGF, and ⌬Raf-1:ER activity was detected in ⌬Raf-1:ER cells treated with estradiol. Addition of 10 nM estradiol to cells that had been in N2 medium at 39ЊC for 2 days resulted in Ͼ6-fold ⌬Raf-1:ER activation by 60 min (Fig. 5C and D) . Similar induction of ⌬Raf-1:ER activity by estradiol was observed at 33ЊC, but the level of ⌬Raf-1:ER activity at this temperature was approximately two-to threefold higher, reflecting in part the higher level of protein at that temperature ( Fig. 5B and D) . The ⌬Raf-1:ER activity was specifically due to the expression of the ⌬Raf-1:ER construct, as shown by the lack of activity in antiestrogen receptor immunoprecipitates from cells treated with either FGF or EGF or with serum (data not shown). Furthermore, no significant endogenous Raf-1 activity was detected in response to 10 nM estradiol in the parent H19-7 cells (data not shown).
Temperature-dependent activation of MEK and ERKs by
Raf. The extent of MEK activation in response to ⌬Raf-1:ER stimulation was dependent on the temperature (Fig. 6 ). At 33ЊC, the temperature at which T antigen is active, stimulation of ⌬Raf-1:ER with 10 nM estradiol resulted in the constitutive activation of MEK, as assayed by phosphorylation of kinaseinactive ERK1 in crude cell extracts. Similar results were obtained when MEK activity was determined by Western blot analysis of tyrosine-phosphorylated kinase-inactive ERK1 or when MEK was immunoprecipitated and assayed directly for activity (data not shown). The level of MEK activation (increase of Ͼ5-fold) at 33ЊC in response to estradiol-stimulated ⌬Raf-1:ER was comparable to that observed after treatment of the cells for 5 min with either EGF or serum. On the other hand, when cells were shifted to 39ЊC to inactivate T antigen, only low MEK activity (Ͻ2.0-fold induction) was detectable in response to 10 nM estradiol-induced ⌬Raf-1:ER. Thus, MEK activity was induced in response to estradiol treatment at 39ЊC, FIG. 7 . Time course of stimulation of ERK activity by estradiol in ⌬Raf-1:ER cells. Cells were grown as described in the legend to Fig. 2 . Ten micrograms of cell extract was loaded in each lane, and ERK activity was assayed by the in-gel kinase assay with MBP as a substrate as described in Materials and Methods. The gels were dried and then exposed to X-ray film for autoradiography. but it was significantly lower than the comparable ⌬Raf-1:ER activity.
MAPK (ERK1 and -2) activation in the ⌬Raf-1:ER cells in response to estradiol was monitored at both 33 and 39ЊC, using an in-gel renaturation assay (Fig. 7) . After induction of ⌬Raf-1:ER at 33ЊC with 1 M estradiol, ERK1 and -2 were constitutively activated from 2 min after estradiol addition until at least 33 h following treatment. The levels of ERK activation at 33ЊC were as high as or higher than after treatment with FGF for 5 min (Fig. 7F) . At 39ЊC, however, ERK activation in response to 1 M estradiol induction of ⌬Raf-1:ER was less robust, peaked around 30 min, and was barely detectable by 3 h after treatment (Fig. 7E) . Although estradiol treatment of the parent H19-7 cells stimulated some activation of ERK as well (Fig. 7B) , this was insufficient to induce differentiation.
The temperature-dependent difference in ERK activation was even more apparent at low estradiol concentrations. At 33ЊC, ⌬Raf-1:ER cells treated with 20 nM estradiol showed detectable ERK activity by 10 min after treatment, which reached a peak (Ͼ5-fold) by 1 h and remained robust even after 5 h of estradiol treatment ( Fig. 7D and G) . In contrast, induction at 39ЊC of ⌬Raf-1:ER with 10 to 20 nM estradiol yielded a low increase in ERK activity over background, comparable to that observed in the parent H19-7 cells in response to 10 nM estradiol (Fig. 7A to C) . To gain a more accurate estimation of the level of ERK stimulation, ERK activity in immunoprecipitates was also assayed directly. Induction at 39ЊC of ⌬Raf-1:ER with 10 nM estradiol yielded a small increase in ERK activity over background (Ͻ2-fold) (Fig. 7H) . These results indicate that ERK-1 and -2 are constitutively activated at 33ЊC, the temperature at which T antigen is active, and are also stimulated but to a significantly lower extent at 39ЊC.
Transiently transfected MEK will not induce neuronal differentiation. The previous results suggest that prolonged MAPK activation may not be sufficient for neuronal differentiation of H19-7 cells within 36 h of estradiol treatment at 33ЊC. To determine whether constitutive MAPK activity is sufficient to induce differentiation of cells at 39ЊC in the absence of an immortalizing gene, constitutively activated MEK was introduced into cells by either transient transfection or microinjection. Initially, the effect of transfected MEK on ERK activation was tested. ⌬Raf-1:ER cells were transfected transiently at 33ЊC with HA-ERK2 and either a control plasmid (CMV-EE) or constitutively activated MEK-2E expression plasmid that encodes a protein with two glutamic acid residues substituted at the sites of the activating serine residues. Cells were either left at 33ЊC or transferred to 39ЊC in N2 medium. Before harvesting, cells were treated with estradiol for 30 min or with growth factor (EGF or FGF) for 5 min. At 36 h following transfection with MEK-2E and HA-ERK, the HA-ERK2 was immunoprecipitated and assayed for kinase activity, using MBP as a substrate. As shown in Fig. 8 , expressed MEK-2E was effective at generating constitutively active MAPK at both 33 and 39ЊC, and the activity was comparable to that induced by growth factor treatment of the cells (Fig. 8A and B) . Transfection with ⌬MEK1:ER, a plasmid expressing activated MEK fused to the estradiol binding domain of the estrogen receptor, stimulated HA-ERK2 to the same extent as MEK-2E at 39ЊC (data not shown). Higher HA-ERK2 activity in MEK-2E-expressing cells was not due to differences in HA-ERK2 protein expression (Fig. 8A, lower  panel) .
To determine the phenotype of the cells expressing MEK-2E, cells were cotransfected with MEK-2E and pCMV-␤-gal as a reporter gene. At 12 h following transfection, cells were shifted to 39ЊC in N2 medium and monitored during the next 24 to 48 h for differentiation as defined by morphological changes and neurite formation. Initially, the ⌬Raf-1:ER vector was transfected into H19-7 cells as a control for the differentiation efficiency. In the presence of 1 M estradiol, 47% of the ␤-galactosidase-expressing cells were differentiated ( Fig. 9C  and D ; Table 1 ). In contrast, in the absence of estradiol, 90% of the ␤-galactosidase-expressing cells counted were undifferentiated ( Fig. 9A and B ; Table 1 ). Furthermore, 95% of the cells that did not express ␤-galactosidase activity were undifferentiated. These results confirm that transient expression and activation of ⌬Raf-1:ER led to differentiation of H19-7 cells.
When the MEK-2E vector was cotransfected with ␤-galactosidase into ⌬Raf-1:ER cells, 87% of the ␤-galactosidaseexpressing cells remained undifferentiated in the absence of estradiol ( Fig. 9E and F; Table 1 ). After induction of ⌬Raf-1:ER with 1 M estradiol, 83% of the ␤-galactosidase-expressing cells were differentiated. Similar results were obtained after bFGF treatment (data not shown), indicating that the transfected cells are capable of undergoing differentiation. To confirm that the majority of cells expressing ␤-galactosidase also expressed the transfected MEK, similar experiments were conducted with the ⌬MEK1:ER construct instead of MEK-2E. HA-ERK activity was assayed with MBP as a substrate as described in Materials and Methods. The reaction mixtures were resolved by SDS-PAGE, blotted onto a nitrocellulose membrane, and exposed to a X-ray film for autoradiography. The 1) . After being shifted to 39ЊC in N2 medium, the cells were either untreated (A, B, E, and F) or treated with 1 M estradiol (E2) (C, D, G, and H). Cells were assayed for ␤-galactosidase expression and staining with X-Gal as described in Materials and Methods. Cells were visualized by either phase-contrast microscopy (A, C, E, and G) or light microscopy (B, D, F, and H) at a magnification of ϫ200. In phase-contrast micrographs (A, C, E, and G), some of ␤-galactosidase-expressing cells are indicated by arrowheads.
Results from two independent experiments indicated that 74% Ϯ 6% of the cells coexpressed ⌬MEK1:ER and ␤-galactosidase, as determined by immunostaining with antibodies to the estrogen receptor and ␤-galactosidase, respectively. This finding suggests that even in the absence of functional large T antigen, constitutive ERK activation for 36 h is not sufficient for neuronal differentiation of H19-7 cells.
Microinjected MEK will not induce neuronal differentiation. To confirm these results, plasmids encoding activated MEK were also introduced into cells by microinjection, and the effect on neuronal differentiation was determined. The efficiency of expression of microinjected plasmids was initially determined by coinjecting plasmid pCMV-␤-gal along with rat IgG protein into the nuclei of ⌬Raf-1:ER cells. The results of two independent experiments show 89% Ϯ 1% of the injected cells, monitored by immunostaining with antibody against rat IgG, also express ␤-galactosidase (Fig. 10) . When plasmids ⌬MEK1:ER and pCMV-␤-gal were coinjected, a similar colocalization of the expressed proteins was observed by immunostaining (data not shown).
To demonstrate that the microinjected cells expressing activated MEK had elevated levels of ERK activity, ⌬Raf-1:ER cells microinjected with MEK-2E were cultured for 46 h, shifted to 39ЊC in N2 defined medium for 2 h, and then stained with an antibody directed against the activated, phosphorylated form of ERK. In contrast to uninjected cells, in which no staining was detected (Fig. 11C and D) , both cells microinjected with MEK-2E (Fig. 11A and B ) and a population of uninjected cells that had been stimulated with EGF for 5 min (Fig. 11E and F) reacted with the antibody. These results indicate that microinjection of MEK-2E results in ERK activation.
Having established the efficiency and efficacy of MEK expression, we determined whether microinjected MEK induced neuronal differentiation. ⌬Raf-1:ER cells were microinjected with rat IgG and the MEK-2E plasmid. After 24 h at 39ЊC in N2 medium, cells were immunostained with an antibody against rat IgG and evaluated for differentiation. While a control culture of uninjected ⌬Raf-1:ER cells treated with 1 M estradiol fully differentiated under these conditions (Fig. 12C) , no differentiation of cells injected with MEK-2E was observed ( Fig. 12A and B) . Similar results were obtained when H19-7 cells were injected with a plasmid encoding ⌬MEK1-ER, which transforms 3T3 cells in an estradiol-dependent manner (18b), and immunostained with an anti-estrogen receptor antibody (Fig. 13) . When H19-7 cells were injected with MEK-2E, only 1 of 29 injected cells was differentiated after 3 days at 39ЊC in N2 medium (data not shown). These results indicate that constitutive activation of MEK and MAPK is not sufficient to induce differentiation of the H19-7 hippocampal neuronal cells at 39ЊC.
DISCUSSION
The studies presented here demonstrate that expression of ⌬Raf-1:ER or v-raf can differentiate the rat hippocampal cell line H19-7. ⌬Raf-1, MEK, and ERK activities following estradiol treatment remained elevated at 33ЊC, the temperature at which T antigen is active. Despite prolonged MEK and ERK activation at 33ЊC, differentiation occurred within 36 h only at 39ЊC. While ⌬Raf-1 was highly activated in response to 10 nM estradiol at both temperatures, the activation of MEK, ERK1, and ERK2 was significantly lower when cells were shifted to 39ЊC to inactivate T antigen. Furthermore, expression of constitutively activated MEK, which led to constitutive activation of ERKs, was insufficient to induce differentiation at 39ЊC. These results suggest that prolonged activation of MEK, ERK1, and ERK2, in the presence or absence of functional T antigen, is not sufficient for differentiation of H19-7 neuronal C.
B.
A. Previous studies have suggested the existence of a MAPKindependent signal transduction pathway for Raf. PC12 cells transfected with the activated raf-1 oncogene were reported to differentiate (35) without detectable activation of MAPK (36) . Activation of MAPK by the oncogenes ras and raf was observed in NIH 3T3 cells but not in Rat-1a cells (12) . Similarly, expression of the ⌬Raf-1:ER protein in Rat 1a cells led to activation of MEK by estradiol but no detectable stimulation of ERK1 and -2 (29) . In addition, a kinase activity distinct from ERK that is activated by Raf-1 and phosphorylates c-fos has recently been described (1) . Finally, Raf-1 has recently been shown to activate cdc25, a cell cycle-regulated phosphatase (11) . These data suggest that the effects of Raf can be mediated by MEK and/or ERK-independent signal transduction pathways.
The question of whether sustained MAPK activation is sufficient for PC12 cell differentiation is not entirely resolved at present. Microinjection of constitutively activated MEK (6), Xenopus MAPKK (10), or MAPK (10) has been shown to induce differentiation of PC12 cells as rapidly as 24 h (6).
However, two very recent reports based on expression of Trk (23) and platelet-derived growth factor (34) mutant receptors suggest that activation of the Ras/Raf/MAPK pathway by nerve growth factor or platelet-derived growth factor is not sufficient for differentiation of PC12 cells within 6 days, the normal differentiation time for PC12 cells. One possible explanation for this discrepancy is that superphysiological expression of MEK or MAPK leads to differential regulation of signaling pathways compared with stimulation in response to growth factors.
It is possible to induce extended duration of the MAPK signal and differentiation in PC12 cells by overexpression of the EGF or insulin receptor (6, 32) . We have similarly noted that EGF induces many of the same genes as FGF in H19-7 cells (12a), but the level of induction by EGF is significantly decreased, consistent with the suggestion that enhancing the magnitude of the growth factor signal is critical for differentiation. These results clearly implicate magnitude of signal as well as cellular environment in determining physiological outcomes of signaling pathways.
Our results indicate that sustained MAPK activation is not sufficient for differentiation of H19-7 cells within 1 to 2 days of stimulation either in the presence or in the absence of func- tional large T antigen. The lack of differentiation by Raf within 2 days at 33ЊC is undoubtedly related to the presence of large T antigen, which may interact with nuclear proteins required for the rapid differentiation response. However, the H19-7 cells, even in the presence of functional T antigen, can be induced to differentiate by activated Raf after a significant lag time. Clearly, constitutive ERK activation is not sufficient to induce this differentiation in a timely fashion, suggesting that another factor that needs to build up over time is required. A factor that is induced by ⌬Raf-1:ER and leads to eventual activation of other signaling pathways has also been noted previously (19) . It is possible that a similar phenomenon is occurring in PC12 cells, which normally take 6 days to differentiate in response to growth factors. It should be noted that PC12 is a transformed cell line, but in this case the oncogene has not been identified. Therefore, it is possible that PC12 cells, like the H19-7 cells that express functional T antigen, have additional factors that may alter the normal signaling events in the cell.
The observation that MEK and MAPK activation is not sufficient for neuronal differentiation of H19-7 cells suggests that there may be some differences in the differentiation pathways for the hippocampal H19-7 cells and PC12 cells. In H19-7 cells, expression of constitutively activated MEK in H19-7 cells by transfection or microinjection for 36 h was not sufficient to induce differentiation. Furthermore, the differentiation by activated Raf did not appear to result from overactivation of MEK or MAPK. In particular, stimulation of ⌬Raf-1:ER at low estradiol concentrations led to limited activation of MEK and MAPK, and the time course of differentiation was similar to that induced by FGF. Since PC12 cells are transformed, it is possible that they express one or more genes that account for the differences observed between the two cell lines when MEK is overexpressed.
The activation state of ⌬Raf-1:ER, MEK, and the ERKs in H19-7 cells varied significantly in response to temperature shift or a specific activator, suggesting that phosphatases may play an important regulatory role. At 33ЊC, the temperature at which cells express functional T antigen, the levels of MEK and MAPK activation were consistently high, implying either that an inhibitor of phosphatases was constitutively expressed (or induced) or that the expression of MAPK phosphatases was repressed. The phosphatase inhibitors okadaic acid and vanadate have been shown to enhance the level of MAPK activation in Raf-stimulated Rat-1a cells (29) , and we have observed some activation of MAPK by these phosphatase inhibitors in H19-7 cells (15a). These results are consistent with a hypothesis that large T antigen negatively regulates the activity of cellular phosphatases that may be constitutively expressed or induced by activation of the MAPK cascade. One precedent for such regulation is the inactivation of the phosphatase PP2A by the direct binding of small t antigen (30) . While the mechanism by which T antigen may affect phosphatase activity is not known, other possibilities include direct transcriptional regulation of phosphatases or phosphatase inhibitors. One family of dual-specificity phosphatases that act on MAPK and are transcriptionally regulated in response to growth factors is the MKP-1 family (31) . The regulation of these and other phosphatases by T antigen is under investigation.
These results illustrate another advantage of the conditionally immortalized H19-7 cell system. The ability to identify and manipulate the immortalization gene encoding large T antigen in the presence or absence of a differentiating signal enables one to assess the effect of the immortalization gene on signaling pathways. In addition, because T antigen is not active at physiological temperatures, it is possible to graft H19-7 cells into rat brains to determine the effect of potential differentiating genes such as raf-1 in vivo. It will be interesting to compare the effect of constitutively expressed Raf on the differentiation state and survival of these cells in vivo.
The observation that cells expressing functional T antigen can still express neurites in response to Raf-1 activation suggests that the initiation of differentiation is not just a consequence of the cessation of cell growth. Thus, the cells appear to be responding to both a growth-promoting signal (large T antigen) and a differentiating signal (Raf-1), and the ultimate endpoint is presumably determined by the relative potency of the two signals. We have noted that cells expressing v-raf constitutively have lower levels of activated Raf than ⌬Raf-1:ER cells after induction with estradiol (data not shown); any cells that differentiated in response to a strong constitutive Raf signal would have been lost during selection. A similar proliferation of cells that partially undergo differentiation has also been observed in Drosophila mutants (32a). Activation of ⌬Raf-1:ER at 33ЊC with estradiol will also eventually cause neurite formation, but there is a significant lag time consistent with the requirement for an additional factor. Thus, it is possible that Raf uses different pathways for promoting differentiation of neuronal cells depending on the presence or absence of a strong growth-promoting signal.
Whether MEK or ERK activation is required for differentiation of H19-7 cells has not yet been determined. Although MEK and ERK activation levels are low under some conditions of differentiation, it is still possible that only a minimal stimulation is necessary to promote differentiation. Alternatively, there are many other potential signaling factors that could play a role. For example, multiple MEKs and MAPKs have been described in mammalian cells. To date, only three VOL. 16, 1996 DIFFERENTIATION OF NEURONAL CELLS BY Raf 1469 MAPK-related pathways have been well characterized: the ERK, the JNK/SAPK, and the p38/HOG pathways (reviewed in reference 14) . Recent studies have shown that JNK/SAPK and p38/HOG are stress-related kinases that are not significantly activated by tyrosine kinase-activating growth factors or Raf, observations that we have confirmed in studies using H19-7 cells (reference 7, 21, and 37 and data not shown). The nature of the other signaling pathways that mediate the effects of Raf on neuronal differentiation of H19-7 cells are under investigation.
